Pharmacokinetic–pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan

This publication has 32 references indexed in Scilit:

• Comparative effects of serotonergic agonists withvarying efficacy at the 5-HT_1Areceptor on core body temperature: modification by the selective 5-HT_1Areceptor antagonist WAY 100635
  Journal of Psychopharmacology, 1999
• Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge.
  Psychopharmacology, 1997
• The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects
  European Journal of Pharmacology, 1995
• Regulation of 5‐HT receptors by corticosteroids: where do we stand?
  Fundamental & Clinical Pharmacology, 1995
• A comparison of the neuro‐endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.
  British Journal of Clinical Pharmacology, 1995
• Comparison of four basic models of indirect pharmacodynamic responses
  Journal of Pharmacokinetics and Biopharmaceutics, 1993
• Physiopharmacological interactions between stress hormones and central serotonergic systems
  Brain Research Reviews, 1993
• Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat
  European Journal of Pharmacology, 1991
• A new look at the statistical model identification
  IEEE Transactions on Automatic Control, 1974
• Parameters of novelty, shock predictability and response contingency in corticosterone release in the rat
  Physiology & Behavior, 1973